Literature DB >> 8146453

Oral bioavailability of sulphadiazine and trimethoprim in fed and fasted pigs.

P Nielsen1, N Gyrd-Hansen.   

Abstract

The disposition of sulphadiazine (SDZ) and trimethoprim (TMP) was measured after intravenous and oral administration. Six healthy pigs weighing 17 to 34 kg received 20 mg kg-1 SDZ plus 4 mg kg-1 TMP intravenously, and 40 mg kg-1 SDZ plus 8 mg kg-1 TMP orally in both a fed and a fasted condition in a three-way cross-over design. After intravenous administration SDZ and TMP were present in plasma for 30 and 12 hours, respectively. The volume of distribution was 0.5 litre kg-1 bodyweight for SDZ and 1.8 litre kg-1 bodyweight for TMP. The oral bioavailabilities for SDZ and TMP in the fed pigs were 85 per cent and 92 per cent, and in the fasted pigs 89 per cent and 90 per cent, respectively. Although the presence of food did not affect the almost complete absorption of both drugs, it did prolong the absorption phase. Mean absorption time was nearly twice as long in the fed as in the fasted pig. Based on bioavailability and the resulting plasma concentrations it is concluded that the oral administration of SDZ and TMP was efficient in both the fed and fasted pigs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8146453     DOI: 10.1016/0034-5288(94)90195-3

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  Pharmacokinetics and oral bioavailability of sulfadiazine and trimethoprim in broiler chickens.

Authors:  K Baert; S De Baere; S Croubels; P De Backer
Journal:  Vet Res Commun       Date:  2003-05       Impact factor: 2.459

2.  Residues of chlortetracycline, doxycycline and sulfadiazine-trimethoprim in intestinal content and feces of pigs due to cross-contamination of feed.

Authors:  Laura E J Peeters; Els Daeseleire; Mathias Devreese; Geertrui Rasschaert; Annemieke Smet; Jeroen Dewulf; Marc Heyndrickx; Hein Imberechts; Freddy Haesebrouck; Patrick Butaye; Siska Croubels
Journal:  BMC Vet Res       Date:  2016-09-20       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.